This news out this morning - Sunday, July 11th for a rare

New Post Public Reply Private Reply Replies (2) Message Board
Megashear InvestWisely #1552
460
This news out this morning - Sunday, July 11th for a rare weekend press release, It is also on the company website under the NEWS tab.

https://www.marketscreener.com/quote/stock/ME...-35832798/

The important part of the release:

Mexus Gold US : To Perform Initial Shipment Of Activated Carbon

07/11/2021 | 11:58am EDT

CABORCA, Mexico, July 11th, 2021 - Mexus Gold US (OTCQB: MXSG) ('Mexus' or the 'Company) announced that the company will be shipping approximately one ton of activated carbon to the U.S. for processing this week. It is believed that this material contains up to 4000 grams Au equivalent.
'The first shipment of carbon for processing is a huge milestone for Mexus with the resulting cash flow allowing us to step up production. The heap leach pad returns continue to be excellent and volume should improve as we expand the pad footprint.' added Mexus CEO Paul Thompson.



Good news. Hope it means Mexus can self-finance operations without further toxic loans. The first part of making money is to stop losing money - hope we're there and for the first time.

At the bottom of the Market Screener page a link list to prior releases including Management Discussion from the recent Annual Report - easier to read this doc than paging thru the complete 10-K.

Just scan your eyes down the titles of the past five year's worth of press releases for the words "production" and "progress". They've been used a lot but this one today reads and feels like the words are more meaningful.

Go Mexus.

rjw/mkc

Mexus Gold US (MXSG) Stock Research Links

MXSG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Future Growth of Diamond Mining Market to Reach $85.63 Billion

Updated Category News Views 201

Diamond Mining Market Insights and Growth Prospects Recent insights into the diamond mining market suggest a significant shift, with expectations that the market will reach a value of USD 85.63 billion in the near future. Currently, the market stands at approximately USD 60.25 billion and is poised for substantial growth driven by a surge in demand for luxury diamond...

Continue Reading
Generational Group Facilitates T-Shirt Express Acquisition

Updated Category News Views 176

Generational Group Assists in Selling T-Shirt Express Generational Group, a well-respected global advisory firm in mergers and acquisitions, has successfully supported the sale of its client, T-Shirt Express, to Tampa Promotions, LLC. This acquisition marks an important milestone in the field of custom apparel solutions. T-Shirt Express: A Custom Apparel Powerhouse...

Continue Reading
Nanobiotix Partners with Healthcare Royalty for $71 Million Deal

Updated Category News Views 174

Nanobiotix Strategic Partnership with HealthCare Royalty Nanobiotix (Euronext: NANO – NASDAQ: NBTX), a pioneering biotechnology company focused on advancing treatment modalities for cancer, has recently announced an innovative financing agreement with HealthCare Royalty (HCRx) that could provide the company with up to $71 million in non-dilutive funding. This...

Continue Reading
Get Ready for the 2025 Collegiate Club Championships!

Updated Category News Views 48

Exciting News for Triathlon Fans Over 1,000 of the country’s top collegiate triathletes are getting ready for an unforgettable showdown at the upcoming 2025 USA Triathlon Collegiate Club National Championships. This eagerly awaited event, hosted by CLASH Endurance, will take place at the Homestead-Miami Speedway. Athletes representing more than 80 collegiate clubs from...

Continue Reading
Johnson & Johnson's New Injection Revolutionizes Lung Cancer Care

Updated Category News Views 121

FDA Grants Approval for Innovative Injection by Johnson & Johnson In a groundbreaking announcement, the U.S. Food and Drug Administration (FDA) has given the green light to Johnson & Johnson for their new product, Rybrevant Faspro (amivantamab and hyaluronidase-lpuj). This represents a significant leap in the treatment for patients with epidermal growth factor receptor...

Continue Reading